156 related articles for article (PubMed ID: 25832410)
1. PLD3 variants in population studies.
van der Lee SJ; Holstege H; Wong TH; Jakobsdottir J; Bis JC; Chouraki V; van Rooij JG; Grove ML; Smith AV; Amin N; Choi SH; Beiser AS; Garcia ME; van IJcken WF; Pijnenburg YA; Louwersheimer E; Brouwer RW; van den Hout MC; Oole E; Eirkisdottir G; Levy D; Rotter JI; Emilsson V; O'Donnell CJ; Aspelund T; Uitterlinden AG; Launer LJ; Hofman A; Boerwinkle E; Psaty BM; DeStefano AL; Scheltens P; Seshadri S; van Swieten JC; Gudnason V; van der Flier WM; Ikram MA; van Duijn CM
Nature; 2015 Apr; 520(7545):E2-3. PubMed ID: 25832410
[No Abstract] [Full Text] [Related]
2. PLD3 gene variants and Alzheimer's disease.
Hooli BV; Lill CM; Mullin K; Qiao D; Lange C; Bertram L; Tanzi RE
Nature; 2015 Apr; 520(7545):E7-8. PubMed ID: 25832413
[No Abstract] [Full Text] [Related]
3. PLD3 in non-familial Alzheimer's disease.
Heilmann S; Drichel D; Clarimon J; Fernández V; Lacour A; Wagner H; Thelen M; Hernández I; Fortea J; Alegret M; Blesa R; Mauleón A; Roca MR; Kornhuber J; Peters O; Heun R; Frölich L; Hüll M; Heneka MT; Rüther E; Riedel-Heller S; Scherer M; Wiltfang J; Jessen F; Becker T; Tárraga L; Boada M; Maier W; Lleó A; Ruiz A; Nöthen MM; Ramirez A
Nature; 2015 Apr; 520(7545):E3-5. PubMed ID: 25832411
[No Abstract] [Full Text] [Related]
4. PLD3 and sporadic Alzheimer's disease risk.
Lambert JC; Grenier-Boley B; Bellenguez C; Pasquier F; Campion D; Dartigues JF; Berr C; Tzourio C; Amouyel P
Nature; 2015 Apr; 520(7545):E1. PubMed ID: 25832408
[No Abstract] [Full Text] [Related]
5. Rare Variants in PLD3 Increase Risk for Alzheimer's Disease in Han Chinese.
Tan MS; Zhu JX; Cao XP; Yu JT; Tan L
J Alzheimers Dis; 2018; 64(1):55-59. PubMed ID: 29865074
[TBL] [Abstract][Full Text] [Related]
6. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.
Cruchaga C; Karch CM; Jin SC; Benitez BA; Cai Y; Guerreiro R; Harari O; Norton J; Budde J; Bertelsen S; Jeng AT; Cooper B; Skorupa T; Carrell D; Levitch D; Hsu S; Choi J; Ryten M; Sassi C; Bras J; Gibbs RJ; Hernandez DG; Lupton MK; Powell J; Forabosco P; Ridge PG; Corcoran CD; Tschanz JT; Norton MC; Munger RG; Schmutz C; Leary M; Demirci FY; Bamne MN; Wang X; Lopez OL; Ganguli M; Medway C; Turton J; Lord J; Braae A; Barber I; Brown K; ; Pastor P; Lorenzo-Betancor O; Brkanac Z; Scott E; Topol E; Morgan K; Rogaeva E; Singleton A; Hardy J; Kamboh MI; George-Hyslop PS; Cairns N; Morris JC; Kauwe JSK; Goate AM
Nature; 2014 Jan; 505(7484):550-554. PubMed ID: 24336208
[TBL] [Abstract][Full Text] [Related]
7. Cruchaga & Goate reply.
Cruchaga C; Goate AM
Nature; 2015 Apr; 520(7545):E5-6. PubMed ID: 25832412
[No Abstract] [Full Text] [Related]
8. Cruchaga & Goate reply.
Cruchaga C; Goate AM
Nature; 2015 Apr; 520(7545):E10. PubMed ID: 25832409
[No Abstract] [Full Text] [Related]
9. Rare Variants in PLD3 Do Not Affect Risk for Early-Onset Alzheimer Disease in a European Consortium Cohort.
Cacace R; Van den Bossche T; Engelborghs S; Geerts N; Laureys A; Dillen L; Graff C; Thonberg H; Chiang HH; Pastor P; Ortega-Cubero S; Pastor MA; Diehl-Schmid J; Alexopoulos P; Benussi L; Ghidoni R; Binetti G; Nacmias B; Sorbi S; Sanchez-Valle R; Lladó A; Gelpi E; Almeida MR; Santana I; Tsolaki M; Koutroumani M; Clarimon J; Lleó A; Fortea J; de Mendonça A; Martins M; Borroni B; Padovani A; Matej R; Rohan Z; Vandenbulcke M; Vandenberghe R; De Deyn PP; Cras P; van der Zee J; Sleegers K; Van Broeckhoven C;
Hum Mutat; 2015 Dec; 36(12):1226-35. PubMed ID: 26411346
[TBL] [Abstract][Full Text] [Related]
10. PLD3 in Alzheimer's Disease: a Modest Effect as Revealed by Updated Association and Expression Analyses.
Zhang DF; Fan Y; Wang D; Bi R; Zhang C; Fang Y; Yao YG
Mol Neurobiol; 2016 Aug; 53(6):4034-4045. PubMed ID: 26189833
[TBL] [Abstract][Full Text] [Related]
11. V232M substitution restricts a distinct O-glycosylation of PLD3 and its neuroprotective function.
Demirev AV; Song HL; Cho MH; Cho K; Peak JJ; Yoo HJ; Kim DH; Yoon SY
Neurobiol Dis; 2019 Sep; 129():182-194. PubMed ID: 31121321
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's (AD).
J Pract Nurs; 2009; 59(2):5-7. PubMed ID: 19718998
[No Abstract] [Full Text] [Related]
13. Cognitive phenotypes in Alzheimer's disease and genetic variants in ACE and IDE.
Vardy ER; Brown K; Stopford CL; Thompson JC; Richardson AM; Neary D; Kalsheker N; Morgan K; Mann DM; Snowden JS
Neurobiol Aging; 2012 Jul; 33(7):1486.e1-2. PubMed ID: 21232820
[TBL] [Abstract][Full Text] [Related]
14. Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond.
Cuyvers E; Sleegers K
Lancet Neurol; 2016 Jul; 15(8):857-868. PubMed ID: 27302364
[TBL] [Abstract][Full Text] [Related]
15. Association between genetic variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndrome.
Lee JH; Chulikavit M; Pang D; Zigman WB; Silverman W; Schupf N
Neurosci Lett; 2007 Sep; 425(2):105-9. PubMed ID: 17826910
[TBL] [Abstract][Full Text] [Related]
16. Quantification and characterization of the 5' exonuclease activity of the lysosomal nuclease PLD3 by a novel cell-based assay.
Cappel C; Gonzalez AC; Damme M
J Biol Chem; 2021; 296():100152. PubMed ID: 33288674
[TBL] [Abstract][Full Text] [Related]
17. Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls.
Bellenguez C; Charbonnier C; Grenier-Boley B; Quenez O; Le Guennec K; Nicolas G; Chauhan G; Wallon D; Rousseau S; Richard AC; Boland A; Bourque G; Munter HM; Olaso R; Meyer V; Rollin-Sillaire A; Pasquier F; Letenneur L; Redon R; Dartigues JF; Tzourio C; Frebourg T; Lathrop M; Deleuze JF; Hannequin D; Genin E; Amouyel P; Debette S; Lambert JC; Campion D;
Neurobiol Aging; 2017 Nov; 59():220.e1-220.e9. PubMed ID: 28789839
[TBL] [Abstract][Full Text] [Related]
18. Implication of common and disease specific variants in CLU, CR1, and PICALM.
Ferrari R; Moreno JH; Minhajuddin AT; O'Bryant SE; Reisch JS; Barber RC; Momeni P
Neurobiol Aging; 2012 Aug; 33(8):1846.e7-18. PubMed ID: 22402018
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's Disease Variants with the Genome-Wide Significance are Significantly Enriched in Immune Pathways and Active in Immune Cells.
Jiang Q; Jin S; Jiang Y; Liao M; Feng R; Zhang L; Liu G; Hao J
Mol Neurobiol; 2017 Jan; 54(1):594-600. PubMed ID: 26746668
[TBL] [Abstract][Full Text] [Related]
20. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease.
Brouwers N; Sleegers K; Engelborghs S; Maurer-Stroh S; Gijselinck I; van der Zee J; Pickut BA; Van den Broeck M; Mattheijssens M; Peeters K; Schymkowitz J; Rousseau F; Martin JJ; Cruts M; De Deyn PP; Van Broeckhoven C
Neurology; 2008 Aug; 71(9):656-64. PubMed ID: 18565828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
